Durlav Prasad Bora

Dr. Durlav Prasad Bora


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2024 in Viruses
Verified
Journal Article
Open access
PDF file
NBNagendra Nath Barman
Nagendra Nath Barman
ABArpita Bharali
Arpita Bharali
DBDurlav Prasad Bora
Durlav Prasad Bora
BDBiswajit Dutta
Biswajit Dutta
MBMousumi Bora
Mousumi Bora
LBLukumoni Buragohain
Lukumoni Buragohain
The present study aimed to investigate the episodes of per-acute mortality due to peste des petits ruminants (PPR) that resulted in the death of 30 animals of different species of cervids, namely, barking deer, four-horned antelope, hog deer, thamin, and mouse deer in the State Zoo of Assam, a northeastern state of India. The affected animals showed no to limited clinical signs. However, the necropsy and histopathological findings were highly suggestive of PPR virus (PPRV) infection observed in domestic small ruminants. Representative tissue samples were screened for the presence of PPRV along with blue tongue virus (BTV) and epizootic hemorrhagic disease virus (EHDV) using RT-PCR or RT-qPCR and were found to be positive for PPRV. Considering the sudden outbreak of PPR in captive cervids, we sought to determine the role of domestic goats as the potential spillover host. To verify that, archived tissue samples of domestic goats collected during PPRV outbreaks in nearby localities and slaughtered goats used as meat for Carnivorous animals in the State Zoo were also screened and found to be positive for PPRV in RT-PCR. Phylogenetic analysis based on the Nucleocapsid (N) protein gene of PPRV from infected cervids, domestic goats, and goat meat revealed the virus to be of Lineage IV origin. Our findings provide evidence of probable spillover of PPRV from domestic goats to captive endangered cervids and circulation of Lineage IV PPRV strains among the small-ruminant population of this region.

16 July 2024 in Indian Journal of Animal Research
Verified
Journal Article
Open access
PDF file
DHDipankar Hazarika
Dipankar Hazarika
DBDurlav Prasad Bora
Durlav Prasad Bora
JBJayanta Sarmah Boruah
Jayanta Sarmah Boruah
YBYasmin Begum
Yasmin Begum
ASAnisha Sultana
Anisha Sultana
DKDhruba Jyoti Kalita
Dhruba Jyoti Kalita
Background: The present study was carried out to evaluate in-vitro toxicity associated with chitosan nanoparticles, Gantrez® nanoparticles and poly-lactide co-glycolide (PLG) microparticle in Vero cell line. The cytotoxicity of all three micro/nano-particles was assessed using different concentration. Methods: For each concentration of these delivery systems, the confluent monolayer of Vero cells was treated for a period of 48 hours and studied for morphological alteration and cell survivability after the treatment. Results: It was observed that the different concentrations of chitosan nanoparticles and Gantrez® nanoparticles did not have significant effect on the cell viability as evident from the non-significant difference between the OD540 of formazan product formed from MTT in treated and untreated cells. The concentration of chitosan nanoparticles and Gantrez® nanoparticles up to 1000 µg/ml did not have any influence in cellular metabolic activities and viability. However, a slight reduction (statistically insignificant) in the cellular viability and metabolic activities were observed when PLG microparticles were used at 1000 µg/ml.

21 June 2025 in Indian Journal of Animal Research
Verified
Journal Article
Open access
PDF file
DADas Adwitiya
Das Adwitiya
DSDilip Kumar Sarma
Dilip Kumar Sarma
RSRajeev Kumar Sharma
Rajeev Kumar Sharma
PBProbodh Borah
Probodh Borah
DBDurlav Prasad Bora
Durlav Prasad Bora
RHRitam Hazarika
Ritam Hazarika
Background: Multidrug resistant strains of Escherichia coli have been causing worldwide outbreaks of food borne diseases in recent years. The emergence of antibiotic-resistant strains of E. coli and the occurrence of transmissible drug resistance among the organism has amplified the complications associated with its control and treatment measures. Data associated with the prevalence, virulence factors and antimicrobial susceptibility of E. coli isolates are needed to be studied in order to develop an effective control strategy for colibacillosis in piggeries. The goal of the investigation was to study the antimicrobial susceptibility pattern and pathotyping of E. coli isolates from diarrhoeic piglets. Methods: 102 rectal swab samples were collected from diarrhoeic piglets of ICAR-AICRP/MSP on Pig, College of Veterinary Science, Assam Agricultural University, Khanapara, ICAR-National Research Centre on Pig, Rani, Guwahati, Assam and from different unorganized farms of the state. These samples were then inoculated in Luria Bertani (LB) broth and incubated aerobically at 37oC for 24 hours followed by sub culturing them in MacConkey’s lactose agar (MLA) and Eosin Methylene Blue (EMB) agar for purification of the suspected E. coli isolates. The isolates were characterized by biochemical tests and motility tests and were pathotyped based on detection of specific virulence genes by multiplex Polymerase Chain Reaction (PCR). Result: Out of 102 rectal swab samples examined, 92 (90.2%) yielded E. coli which included 41 (91.12%) of 45 samples collected from ICAR-AICRP/MSP on Pig, College of Veterinary Science, Assam Agricultural University, Khanapara and 32 (88.89%) of 36 samples from ICAR-National Research Centre on Pig, Rani, Guwahati, Assam and 19 (90.48%) of 21 samples from different unorganized farms. All the 92 E. coli isolates were examined for the presence of stx1, est1, elt1 and eaeA genes using specific primers. Among these isolates, 25 (27.17%) were positive for stx1 gene, 18(19.56%) for est1 gene, 6(6.52%) for elt1 gene, 3 (3.26%) for both genes est1 and elt1 and 12 (13.04%) for eaeA gene. Antimicrobial susceptibility pattern of the isolates revealed that the highest percentage (71.74%) of the isolates were resistant to tetracycline and the least (4.34%) to imipenem.